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Abstract
Herbal medicine represents an alternative for treating dyslipidemia. It has been probed that 
aerial part of Eryngium heterophyllum, a species of medicinal plant that belongs to the fam-
ily Apiaceae, reduces cholesterol by 27% in rats. On the other hand, Amphipterygium ad-
stringens, a Mexican tree exerts a significant hypocholesterolemic effect on rats, lowering 
cholesterol levels by 31%. The aim of this project was to evaluate the PC-300 tea (Eryngium 
heterophyllum egelm + Amphipterygium adstringens) against hypertriglyceridemia. It was a 
non-randomized, descriptive, prospective, longitudinal, and comparative clinical study. Vol-
untary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 
200 mg/day, and 2) PC-300 tea, one cup half an hour before eating. Baseline samples of 
serum total cholesterol and triglycerides were obtained and measured again after 1 month of 
treatment. There were 17 patients (males: 6, females: 11) treated with the tea, with a mean 
age of 49 ± 15 years, and 17 patients (males: 8, females: 9) treated with bezafibrate, with a 
mean age of 44.7 ± 13 years. In the first group, the percentage of triglyceride reduction was 
19.7% (p ≤ 0.05), while in the second group, this was 44.8% (p ≤ 0.001). We conclude that 
consumption of PC-300 reduces triglyceride levels an average of 20% after 1 month.
Keywords: Amphipterygium adstringens; Eryngium heterophyllum egelm; Hypertriglycer-
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in rats [8]; even more so, E. heterophyllum 
possesses anti-inflammatory properties [9]. 
On the other hand, A. adstringens, a Mexi-
can tree known as cuachalalate, exerts a sig-
nificant hypocholesterolemic effect on rats, 
lowering cholesterol levels by 31% [10]. The 
purpose of this study was to verify the effec-
tiveness of the PC-300 tea compared with be-
zafibrate in the clinical field. 
Figure 1. PC-300 tea presentation
Methods
Place and subjects
It is a descriptive, prospective, longitudinal, 
and comparative clinical study with  Clinical-
Trials.gov identifier of NCT03649269 devel-
oped at Ciprés Grupo Médico S.C. (CGM), 
Toluca, Mexico, from January 2014 to De-
cember 2014. 
Patients with hypertriglyceridemia, aged >18 
years and with an educational level at least of 
primary school were invited to participate in 
the study. Patients with hepatic disease were 
excluded, and those missing an appointment 
during the study were discarded from the final 
analysis. Voluntary subjects were assigned 
Introduction
Cardiovascular diseases are the leading cause 
of death worldwide. Among the major risk 
factors for this health problem, dyslipidemia 
is highlighted, being the hypertriglyceridemia 
the most common dyslipidemia in Mexico. 
Of particular concern, the treatments avail-
able for these conditions, while controlling 
the disease, are accompanied by a number of 
adverse effects, in addition to the high cost 
of some of these treatments, which gener-
ate long-term treatment dropout. Therefore, 
the search for novel treatment alternatives is 
necessary. 
Herbal medicine represents an alternative for 
treating dyslipidemia. Among the options, 
Chinese groups have tested several compos-
ites with one or more plant extracts [1-3]. 
Unfortunately, the majority of these studies 
have been conducted in animals. Paradoxi-
cally, despite being one of the countries with 
more biodiversity and with millennial use of 
medicinal plants, Mexico has published a rel-
atively few clinical scientific papers related 
with this topic [4,5].
Speaking about successful experiences with 
herbal medicine, the PC-300 tea (Eryngium 
heterophyllum and Amphipterygium adstrin-
gens) (Figure 1), developed at the University 
of Chapingo, State of Mexico, Mexico, has 
the potential to reduce cholesterol and tri-
glycerides [6,7]. Eryngium heterophyllum is 
a species of medicinal plant native to Mexico 
that belongs to the family Apiaceae; it was 
previously known that the aerial part of E. 
heterophyllum reduces cholesterol by 27% 
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sequentially into two treatment groups: 1) 
fibrate (bezafibrate) 200 mg/day, and 2) PC-
300 tea, one cup half an hour before eating. 
Plants selection
The collected plants were cultured in Tex-
coco, State of Mexico and classified and au-
thenticated by Dr. Erick Estrada Lugo, of the 
Autonomous University of Chapingo, Mexi-
co. The PC-300 is made with the aerial part 
of the E. heterophyllum and with the bark of 
the tree A. adstringens. The full sterile bottle 
weights 240 g and the percentage of grams 
per bottle of each species is 50%.
Tea prescription
The indicated steps for the use of the tea 
were: put a cup of water to boil, then add a 
small spoon of tea and let it simmer 4 min-
utes. Once this is done, it is strained and it 
can be taken 15 to 20 minutes before break-
fast, lunch and dinner.
Sample
To obtain a 90% statistical power with an al-
pha error of 0.05 (two-sided test), to demon-
strate an effect of a 15% reduction in TG 
level in patients when received PC-300, 17 
patients were needed per group. 
Blood samples
Blood samples (5-ml) were taken after an 
8‒12-h fasting period in Vacutainer™ tubes. 
Serum samples were analyzed for choles-
terol (mg/dl), triglycerides (mg/dl) and glu-
cose (mg/dl), using appropriate kits (Randox 
Laboratories Ltd., U.K.) (Vitalab Selectra II, 
Vital Scientific, The Netherlands). Sampling 
times were at baseline and after 1 month with 
either of the two treatments. All tests were 
measured according to standardized proce-
dures recommended by the International Fed-
eration of Clinical Chemistry and Laboratory 
Medicine (IFCC) at Laboratorio Artemisa, 
Toluca, Mexico.
Anthropometric measures
Patients were measured (m) and weighed (kg) 
(Obi, México). Body mass index (BMI) was 
calculated as weight (kg) divided by height 
(m) squared. Blood pressure was measured 
with a calibrated sphygmomanometer (Welch 
Allyn, USA) after 5 min of rest.
Diet
All of the patients were given a low lipid diet. 
Calculated kcal were based on ideal weight 
minus 200 kcal/day if overweight. 
Statistics
Results were expressed as mean ± Standard 
deviation (SD). Differences between ini-
tial vs. final values were compared with the 
Mann-Whitney U test. The normality hypoth-
esis was tested using the Kolmogorov-Smirn-
ov test. A p value of <0.05 was considered 
significant. All tests were performed through 
the SPSS ver. 23 statistical software.
Ethics
The Ethical and Research Committee of 
Ciprés Grupo Médico S.C. (CGM), code 
2014/02, approved this study. The proce-
dures followed were in accordance with the 
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ethical standards of the General Health Law 
of Mexico and were subjected to the ethical 
and moral value judgments of the Helsinki 
Declaration (Fortaleza Brazil). 
 
Results 
There were 17 patients in the group treated 
with PC-300 tea, mean age 49 ± 15.9 years 
(females: 11, males: 6), and 17 were treated 
with bezafibrate (9 females and 8 males), 
mean age 44.7 ± 13 years. We had 12 
dropouts: seven with the tea, and five with 
bezafibrate.
In the first group, the percentage of 
triglyceride reduction was 19.7% (p ≤0.05), 
while in the second group, this was 44.8% 
(p ≤ 0.01). In relation to cholesterol, the 
reduction percentages were 4.8% (p ≤ 0.05) 
and 9.2%, respectively (Table 1).
In the first group, 15 (88.23%) patients 
had diminished triglyceride levels and two 
(11.76%) exhibited increased levels. In 
the second group, the numbers for these 
changes were 16 (94.11%) and one (5.88%), 
respectively. With respect to cholesterol, 
nine patients (52.94%) had reduced levels 
(these same patients demonstrated reduced 
triglycerides) with the PC-300 tea; in 
comparison, 13 patients (76.47%) showed 
this response with bezafibrate.
Regarding gender, in the PC-300 tea group, 
five males (83.33%) and 10 females (90.90%) 
had reduced triglyceride levels. Similarly, in 
the fibrate group, these percentages were 80 
and 100%, respectively.
Table 1. Lipid, glucose and BMI comparison after one month of treatment
Group
Tea Bezafibrate p





27.2 ± 4.2 27.3 ± 4.1 27.2 ± 3.8 27.1 ± 3.6
Cholesterol
 (mg/dl)
212.2 ± 35.5 200.9 ± 31.9 221.5 ± 59 189.9 ± 44.8 ≤ 0.05*ª
Triglycerides





170 ± 93.5 121.7 ± 28.2 133.3 ± 80.5 118.6 ± 56.7 ≤ 0.05*ª
BMI: Body Mass Index. a: in the tea group, b: in the bezafibrate group. * p<0.05, **p<0.001 compared to initial value.
Discussion
Using herbal alternatives to treat dyslipid-
emia is not new. For example, Kurian et al. 
published that the G-400 polyherbal drug 
(Salacia oblonga root, Tinospora cordifolia 
stem, Emblica offinalis Gaertn, Curcuma 
longa, and Gymnema sylvestre) acts as a hy-
polipidemic agent in patients with diabetes 
and also attenuates hyperglycemia [11].
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In the study of E. heterophyllum by Miranda 
Velásquez [7] the results of chemical reac-
tions for the detection of secondary metabo-
lites suggested the presence of the following 
types of compounds: alkaloids in the aque-
ous extract, coumarins only in the aqueous 
and methanol extract and phenolic hydroxyl 
(except ethanolic and methanolic extracts) in 
aqueous extract.
Among other components found in the ex-
tracts of E. heterophyllum, the reduction of 
serum concentrartions of lipids has been ex-
plained by the action of saponins [8].
In our study, regardless of treatment type, 
there was a reduction in triglyceride lev-
els, but the percentage of reduction of tri-
glycerides was higher with the fibrate (44.8% 
± 23.5) than with the PC-300 tea (19.7% ± 
40.6). Notwithstanding this, supplemen-
tations with PC-300 not only reduced tri-
glycerides, but also total cholesterol.
Liu ZL et al reported an analysis of three ran-
domized trials with 170 participants, evalu-
ating Chinese herbal medicines to treat alone 
or in combination with gemfibrozil hypertri-
glyceridemia. All three trials reported results 
in favor of the herbal treatment [12]. In gen-
eral, China is performing a world leadership 
novel research based on herbal medicine to 
lower lipids [13,14]. Mexico, with its millen-
nial use of herbology could follow the same 
trend.
Current treatment strategies directed towards 
dyslipidemia tend to be limited due to ex-
pensive cost of research and sale [15]. By 
contrast, new insights suggest benefits of 
natural agents as treatments for metabolic 
syndrome [16-19]. Following this line, Eryn-
gium heterophyllum as well as Amphipteryg-
ium adstringens can be purchased from local 
markets, but to make it easier, the mix pre-
sentation is already prepared and is afford-
able, economically speaking for low-income 
populations.
In summary, consumption of PC-300 tea 
showed a trend primarily in reducing tri-
glyceride levels; however, there is great vari-
ability in the percentage of decrease among 
patients, which could be due to poor treat-
ment adherence and to the different type 
of dyslipidemia. With this information we 
postulate that use of the PC-300 tea may be 
recommended as a monotherapy or in combi-
nation with drugs, depending on the degree 
of lipid increase, age and comorbidities. Spe-
cifically, PC-300 should be prescribed for 
20‒30% above normal triglyceride values. 
Of course, when taking the tea there are some 
side effects, being the main two a decreased 
consistency of the stools and even diarrhea 
if taken almost immediately previous to the 
food ingestion.
A limitation of the study is the low number 
of patients; this is explained in part due to 
the withdrawal of Bezalip™ (Roche) (beza-
fibrate) from the Mexican market, the drug 
with which we began medical treatment in 
one of the groups. However, a clear advan-
tage of the PC-300 tea is its cost and the ab-
sence of collateral effects. The price of a bot-
tle of 150 g of PC-300 tea is of 6.5 US $ and 
lasts three months, this mean a cost of 2.1 US 
$ per month. By contrast, the monthly cost 
with Bezalip (bezafibrate) is of 24.6 US $, 
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with Controlip (fenofibrate) is 35.3 US $ and 
We can conclude that the PC-300 tea can 
contribute to the lipid profile control with 
a reduction in the TG levels by about 30% 
within one month after beginning this treat-
ment. Further study should be conducted on 
the long-term effect of the tea tested on larg-
er populations.
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